HomeS3F0 • FRA
add
Santhera Pharmaceuticals Holding AG
Previous close
€14.06
Day range
€13.98 - €14.06
Year range
€13.12 - €15.60
Market cap
179.75M CHF
Avg Volume
35.00
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
(CHF) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 12.50M | -74.87% |
Operating expense | 15.05M | 12.70% |
Net income | -13.36M | -134.19% |
Net profit margin | -106.83 | -236.04% |
Earnings per share | — | — |
EBITDA | -6.51M | -118.03% |
Effective tax rate | -0.52% | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 40.92M | 34.75% |
Total assets | 152.49M | 39.09% |
Total liabilities | 124.79M | 151.16% |
Total equity | 27.70M | — |
Shares outstanding | 12.79M | — |
Price to book | 6.48 | — |
Return on assets | -12.63% | — |
Return on capital | -28.20% | — |
Cash Flow
Net change in cash
(CHF) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -13.36M | -134.19% |
Cash from operations | -10.12M | -132.32% |
Cash from investing | -35.50K | 99.70% |
Cash from financing | 23.22M | 557.50% |
Net change in cash | 12.22M | -14.85% |
Free cash flow | -3.90M | -143.49% |
About
Founded
2004
Website
Employees
79